US FDA approves Biogen-Sage Therapeutics pill for postpartum depression By Reuters
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
RyanJLane/E+ via Getty ImagesI covered G1 Therapeutics (NASDAQ:GTHX) in November, when they were talking about when to topline their colorectal ...
© Reuters. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, ...
Autolus Therapeutics (AUTL) Announces Data from AUTO1/22 Trial in Pediatric Acute Lymphoblastic Leukemia Autolus Therapeutics plc (Nasdaq: NASDAQ:), a clinical-stage ...
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing ...
Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Chuck Padala – ...
Sean Anthony Eddy An Institute for Clinical and Economic Review (ICER) report has questioned the price tag of TG Therapeutics, ...
Acorda Therapeutics (ACOR) Granted Nasdaq Extension to Meet Minimum Bid Price Acorda Therapeutics , Inc. (Nasdaq: NASDAQ:) today announced that ...
Andranik Hakobyan Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering. The biotech company didn't ...
solidcolours/E+ via Getty Images Aclaris Therapeutics, Inc. (NASDAQ:ACRS) could be among the U.S.-listed healthcare stocks with strong upside potential U.S. ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.